坤恒顺维(688283) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥64,762,080.19, representing a year-on-year increase of 25.65%[5] - The net profit attributable to shareholders for Q3 2022 was ¥24,670,068.59, reflecting a growth of 41.37% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥23,838,292.86, an increase of 58.71% year-on-year[5] - The net profit attributable to shareholders for the year-to-date period reached ¥36,744,134.88, a significant increase of 68.73% compared to the same period last year[5] - Operating revenue for the first three quarters of 2022 was RMB 123,767,873.97, up 37% from RMB 90,378,616.56 in the same period of 2021[20] - Net profit for the first three quarters of 2022 was RMB 36,744,134.88, an increase of 68% compared to RMB 21,776,744.66 in the previous year[21] - Basic and diluted earnings per share for the first three quarters of 2022 were both RMB 0.46, up from RMB 0.35 in the same period of 2021[22] - The company reported a gross profit margin of approximately 65% for the first three quarters of 2022, compared to 61% in the same period of 2021, indicating improved profitability[20] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥909,693,831.87, which is a 248.20% increase compared to the end of the previous year[6] - The total assets at the end of the reporting period amount to 248.20 million, primarily due to funds raised from the initial public offering[11] - The company's total assets reached RMB 909,693,831.87 as of September 30, 2022, compared to RMB 261,256,490.56 at the end of 2021, indicating a significant growth[19] - Total liabilities decreased to RMB 66,032,225.93 as of September 30, 2022, down from RMB 81,073,541.58 at the end of 2021, indicating better financial health[20] - The company's total equity increased to RMB 843,661,605.94 as of September 30, 2022, compared to RMB 180,182,948.98 at the end of 2021, reflecting strong retained earnings[20] Research and Development - Research and development expenses for Q3 2022 totaled ¥8,604,541.63, accounting for 13.29% of operating revenue, an increase of 3.66 percentage points year-on-year[6] - The total R&D investment for the reporting period is 73.50 million, reflecting the company's commitment to enhancing product competitiveness[11] - Research and development expenses increased to RMB 25,462,746.53 in the first three quarters of 2022, up from RMB 14,151,863.12 in the same period of 2021, reflecting a focus on innovation[20] - R&D investments are expected to continue to drive the enhancement of the company's product lines and core competitiveness[11] Cash Flow - The company reported a net cash flow from operating activities of -¥39,205,355.28 for the year-to-date period[6] - The cash inflow from operating activities was approximately $84.74 million, compared to $80.56 million in the same period of 2021, representing an increase of about 2.7%[23] - The net cash flow from operating activities for the first three quarters of 2022 was -$39.21 million, worsening from -$20.47 million in the first three quarters of 2021[23] - The cash outflow from investing activities in the first three quarters of 2022 was $245.25 million, significantly higher than $6.02 million in the same period of 2021[23] - The net cash flow from financing activities in the first three quarters of 2022 was $604.07 million, a substantial increase from $7.31 million in the first three quarters of 2021[24] - The total cash and cash equivalents at the end of Q3 2022 amounted to $390.16 million, up from $32.64 million at the end of Q3 2021[24] - The company received $646.92 million from investment activities in Q3 2022, compared to $20 million in Q3 2021[24] - The cash outflow for repaying debts in Q3 2022 was $29.90 million, compared to $10 million in Q3 2021[24] Market Strategy - The company’s core product market share has steadily increased, contributing to rapid revenue growth[10] - The overall solution provided around core products has led to increased market demand and sustained performance improvement[10] - The company is focusing on high-end testing and simulation instruments, maintaining a high gross margin[11] - The company plans to expand its product matrix to ensure a continuous source of new business[11] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[20] - The company has seen a decrease in the proportion of selling and administrative expenses relative to current revenue[11]